Adaptimmune

Adaptimmune is an England-based biopharmaceutical company that researches and develops novel cell therapeutics for the treatment of cancer and infectious diseases.

Open jobsJobs
Research Milton, United Kingdom Founded 2008 ~263 employees NASDAQ: ADAP

Work at Adaptimmune in HR or recruiting? Claim this page

Employees
263
-0.4% in the 3 months to Feb 2025
Revenue / employee
$228K
Revenue ~$60M
Stock
ADAP
NASDAQ
12-month attrition
12.2%
Tech: 4.5%
H1B filings, FY2024
1
Sponsors visas

Headcount trend

Adaptimmune went from 194 employees in Mar 2023 to 263 in Feb 2025. Sep 2024 to Feb 2025: 6 people joined, 4 left.

Headcount data through Feb 2025

Org structure

Headcount by department

Other200
Operations28
Engineering10
Finance6
Sales6
Success6
HR4
Marketing3

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering1
Historical LCA Filings
2024
1

Peer reviews

Worked with someone at Adaptimmune?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

National Centre Social Research logoNational Centre Social Research770 employeesERGOMED logoERGOMED690 employeesSygnature Discovery logoSygnature Discovery680 employeesUK Centre Ecology Hydrology logoUK Centre Ecology Hydrology590 employeesGenomics England logoGenomics England560 employeesRoslinCT logoRoslinCT430 employeesElevenLabs logoElevenLabs400 employeesSPT Labtech logoSPT Labtech350 employeesOur Future Health UK logoOur Future Health UK340 employeesBicycle Therapeutics logoBicycle Therapeutics310 employeesIsomorphic Labs logoIsomorphic Labs300 employeesBionical Emas logoBionical Emas250 employees

Adaptimmune FAQ

How many employees does Adaptimmune have?

Adaptimmune has about 263 employees, down 0.4% over the 3 months to Feb 2025.

Does Adaptimmune sponsor H1B visas?

Yes. Adaptimmune filed 1 H1B (LCA) application in FY2024, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.

What is Adaptimmune's revenue per employee?

Adaptimmune makes about $228K in revenue per employee, based on $60M annual revenue and 263 employees.

Is Adaptimmune a public company?

Yes. Adaptimmune is publicly traded under the ticker ADAP on NASDAQ.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.